U.S. Markets open in 8 hrs 15 mins

Amneal Pharmaceuticals, Inc. (AMRX)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
4.1000+0.0600 (+1.49%)
At close: 4:00PM EST
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Currency in USD

Valuation Measures

Premium required to access annual data
Premium required to access monthly data
Subscribe to Premium to download historical data
We’re sorry, we weren’t able to find any data.
Please try reloading the page.

Trading Information

Stock Price History

Beta (5Y Monthly) 1.26
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 35.7900
52 Week Low 32.4000
50-Day Moving Average 34.4714
200-Day Moving Average 34.4463

Share Statistics

Avg Vol (3 month) 31.18M
Avg Vol (10 day) 31.22M
Shares Outstanding 5147.63M
Float 94.39M
% Held by Insiders 110.41%
% Held by Institutions 169.74%
Shares Short (Nov 12, 2020) 46.61M
Short Ratio (Nov 12, 2020) 44.85
Short % of Float (Nov 12, 2020) 47.96%
Short % of Shares Outstanding (Nov 12, 2020) 44.48%
Shares Short (prior month Oct 14, 2020) 46.26M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2019
Most Recent Quarter (mrq)Sep 29, 2020


Profit Margin 3.30%
Operating Margin (ttm)7.94%

Management Effectiveness

Return on Assets (ttm)2.41%
Return on Equity (ttm)2.81%

Income Statement

Revenue (ttm)1.88B
Revenue Per Share (ttm)12.87
Quarterly Revenue Growth (yoy)37.30%
Gross Profit (ttm)496.92M
Net Income Avi to Common (ttm)61.97M
Diluted EPS (ttm)0.4180
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)281.98M
Total Cash Per Share (mrq)1.91
Total Debt (mrq)3.02B
Total Debt/Equity (mrq)838.31
Current Ratio (mrq)2.31
Book Value Per Share (mrq)2.04

Cash Flow Statement

Operating Cash Flow (ttm)222.15M
Levered Free Cash Flow (ttm)75.15M